Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro

BACKGROUND: Gastric cancer (GC) with cisplatin resistance is one of the leading causes of limitations to therapy. Inhibition of apoptosis-stimulating protein of p53 (iASPP) plays a key role in GC. However, the role of iASPP in GC with cisplatin resistance remains unclear. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jianyong, Li, Li, Huang, Chengsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706386/
https://www.ncbi.nlm.nih.gov/pubmed/29161238
http://dx.doi.org/10.12659/MSM.905403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706386/
https://www.ncbi.nlm.nih.gov/pubmed/29161238
http://dx.doi.org/10.12659/MSM.905403

Ejemplares similares